Article
SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Oncotarget - 15 Nov 2016
Huang Yongsheng, Wu Wenting, Nie Meng, Li Chuang, Wang Lin
Abstract excerpt
Mothers against decapentaplegic homolog 7 (SMAD7) inhibits the transforming growth factor-β (TGF-β) signaling pathway, which regulates carcinogenesis and cancer progression. A number of studies have reported that SMAD7 polymorphisms (rs4464148, rs4939827, and rs12953717) are associated with colorectal cancer (CRC) risk, but the results from these studies remain conflicting. To determine a more precise estimation...
Read the complete abstract on PubMed